Description
To help diagnose and monitor the treatment of chronic myelogenous leukemia (CML) and a type of acute lymphoblastic leukemia (ALL). Require previous Quantitative reports.
BCR-ABL Quantitative by PCR
To help diagnose and monitor the treatment of chronic myelogenous leukemia (CML) and a type of acute lymphoblastic leukemia (ALL). Require previous Quantitative reports.
TAT:
Specimen Type:
Molecular Biology Single Test
Other Tests
-
60%
-
60%
-
78%
-
85%
Activated Partial Thromboplastin Time (APTT) Mixing Study
APTT Mixing studies identifies the cause for the raised APTT. This could be due to presence of factor deficiency, Lupus anticoagulant, heparin contamination / therapy or deficiency of fibrinogen
Activated Partial Thromboplastin Time (APTT) Mixing Study
APTT Mixing studies identifies the cause for the raised APTT. This could be due to presence of factor deficiency, Lupus anticoagulant, heparin contamination / therapy or deficiency of fibrinogen
Reviews
There are no reviews yet.